Short-Term Environmental Conditioning Enhances Tumorigenic Potential of Triple-Negative Breast Cancer Cells

Tomography. 2019 Dec;5(4):346-357. doi: 10.18383/j.tom.2019.00019.

Abstract

Tumor microenvironments expose cancer cells to heterogeneous, dynamic environments by shifting availability of nutrients, growth factors, and metabolites. Cells integrate various inputs to generate cellular memory that determines trajectories of subsequent phenotypes. Here we report that short-term exposure of triple-negative breast cancer cells to growth factors or targeted inhibitors regulates subsequent tumor initiation. Using breast cancer cells with different driver mutations, we conditioned cells lines with various stimuli for 4 hours before implanting these cells as tumor xenografts and quantifying tumor progression by means of bioluminescence imaging. In the orthotopic model, conditioning a low number of cancer cells with fetal bovine serum led to enhancement of tumor-initiating potential, tumor volume, and liver metastases. Epidermal growth factor and the mTORC1 inhibitor ridaforolimus produced similar but relatively reduced effects on tumorigenic potential. These data show that a short-term stimulus increases tumorigenic phenotypes based on cellular memory. Conditioning regimens failed to alter proliferation or adhesion of cancer cells in vitro or kinase signaling through Akt and ERK measured by multiphoton microscopy in vivo, suggesting that other mechanisms enhanced tumorigenesis. Given the dynamic nature of the tumor environment and time-varying concentrations of small-molecule drugs, this work highlights how variable conditions in tumor environments shape tumor formation, metastasis, and response to therapy.

Keywords: Fluorescence; bioluminescence; breast cancer; signaling.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Animals
  • Carcinogenesis*
  • Cell Adhesion
  • Cell Count
  • Cell Line, Tumor
  • Cell Proliferation
  • Disease Models, Animal
  • Disease Progression
  • Epidermal Growth Factor / pharmacology
  • Extracellular Signal-Regulated MAP Kinases / pharmacology
  • Female
  • Humans
  • Luminescent Measurements
  • Mechanistic Target of Rapamycin Complex 1 / antagonists & inhibitors
  • Neoplasm Metastasis
  • Proto-Oncogene Proteins c-akt / pharmacology
  • Serum Albumin, Bovine / pharmacology
  • Sirolimus / analogs & derivatives
  • Sirolimus / pharmacology
  • Triple Negative Breast Neoplasms / pathology*
  • Tumor Microenvironment*

Substances

  • Serum Albumin, Bovine
  • ridaforolimus
  • Epidermal Growth Factor
  • Mechanistic Target of Rapamycin Complex 1
  • Proto-Oncogene Proteins c-akt
  • Extracellular Signal-Regulated MAP Kinases
  • Sirolimus